Copyright Reports & Markets. All rights reserved.

Global Herpes Labialis Treatment Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Herpes Labialis Treatment Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Herpes Labialis Treatment Market Size Growth Rate by Product
      • 1.4.2 Acyclovir
      • 1.4.3 Valacyclovir
      • 1.4.4 Famciclovir
      • 1.4.5 Penciclovir
      • 1.4.6 Docosanol
    • 1.5 Market by End User
      • 1.5.1 Global Herpes Labialis Treatment Market Size Growth Rate by End User
      • 1.5.2 Topical
      • 1.5.3 Oral
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Herpes Labialis Treatment Market Size
      • 2.1.1 Global Herpes Labialis Treatment Revenue 2014-2025
      • 2.1.2 Global Herpes Labialis Treatment Sales 2014-2025
    • 2.2 Herpes Labialis Treatment Growth Rate by Regions
      • 2.2.1 Global Herpes Labialis Treatment Sales by Regions
      • 2.2.2 Global Herpes Labialis Treatment Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Herpes Labialis Treatment Sales by Manufacturers
      • 3.1.1 Herpes Labialis Treatment Sales by Manufacturers
      • 3.1.2 Herpes Labialis Treatment Sales Market Share by Manufacturers
      • 3.1.3 Global Herpes Labialis Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Herpes Labialis Treatment Revenue by Manufacturers
      • 3.2.1 Herpes Labialis Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Herpes Labialis Treatment Revenue Share by Manufacturers (2014-2019)
    • 3.3 Herpes Labialis Treatment Price by Manufacturers
    • 3.4 Herpes Labialis Treatment Manufacturing Base Distribution, Product Types
      • 3.4.1 Herpes Labialis Treatment Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Herpes Labialis Treatment Product Type
      • 3.4.3 Date of International Manufacturers Enter into Herpes Labialis Treatment Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Herpes Labialis Treatment Sales by Product
    • 4.2 Global Herpes Labialis Treatment Revenue by Product
    • 4.3 Herpes Labialis Treatment Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Herpes Labialis Treatment Breakdown Data by End User

    6 North America

    • 6.1 North America Herpes Labialis Treatment by Countries
      • 6.1.1 North America Herpes Labialis Treatment Sales by Countries
      • 6.1.2 North America Herpes Labialis Treatment Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Herpes Labialis Treatment by Product
    • 6.3 North America Herpes Labialis Treatment by End User

    7 Europe

    • 7.1 Europe Herpes Labialis Treatment by Countries
      • 7.1.1 Europe Herpes Labialis Treatment Sales by Countries
      • 7.1.2 Europe Herpes Labialis Treatment Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Herpes Labialis Treatment by Product
    • 7.3 Europe Herpes Labialis Treatment by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Herpes Labialis Treatment by Countries
      • 8.1.1 Asia Pacific Herpes Labialis Treatment Sales by Countries
      • 8.1.2 Asia Pacific Herpes Labialis Treatment Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Herpes Labialis Treatment by Product
    • 8.3 Asia Pacific Herpes Labialis Treatment by End User

    9 Central & South America

    • 9.1 Central & South America Herpes Labialis Treatment by Countries
      • 9.1.1 Central & South America Herpes Labialis Treatment Sales by Countries
      • 9.1.2 Central & South America Herpes Labialis Treatment Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Herpes Labialis Treatment by Product
    • 9.3 Central & South America Herpes Labialis Treatment by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Herpes Labialis Treatment by Countries
      • 10.1.1 Middle East and Africa Herpes Labialis Treatment Sales by Countries
      • 10.1.2 Middle East and Africa Herpes Labialis Treatment Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Herpes Labialis Treatment by Product
    • 10.3 Middle East and Africa Herpes Labialis Treatment by End User

    11 Company Profiles

    • 11.1 Teva
      • 11.1.1 Teva Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Teva Herpes Labialis Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Teva Herpes Labialis Treatment Products Offered
      • 11.1.5 Teva Recent Development
    • 11.2 Abbott
      • 11.2.1 Abbott Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Abbott Herpes Labialis Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Abbott Herpes Labialis Treatment Products Offered
      • 11.2.5 Abbott Recent Development
    • 11.3 Sun
      • 11.3.1 Sun Company Details
      • 11.3.2 Company Business Overview
    • 11.3.Sun Herpes Labialis Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Sun Herpes Labialis Treatment Products Offered
      • 11.3.5 Sun Recent Development
    • 11.4 Mylan
      • 11.4.1 Mylan Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Mylan Herpes Labialis Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Mylan Herpes Labialis Treatment Products Offered
      • 11.4.5 Mylan Recent Development
    • 11.5 Pfizer
      • 11.5.1 Pfizer Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Pfizer Herpes Labialis Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Pfizer Herpes Labialis Treatment Products Offered
      • 11.5.5 Pfizer Recent Development
    • 11.6 GlaxoSmithKline
      • 11.6.1 GlaxoSmithKline Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 GlaxoSmithKline Herpes Labialis Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 GlaxoSmithKline Herpes Labialis Treatment Products Offered
      • 11.6.5 GlaxoSmithKline Recent Development
    • 11.7 Dr. Reddy's
      • 11.7.1 Dr. Reddy's Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Dr. Reddy's Herpes Labialis Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Dr. Reddy's Herpes Labialis Treatment Products Offered
      • 11.7.5 Dr. Reddy's Recent Development
    • 11.8 Novartis
      • 11.8.1 Novartis Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Novartis Herpes Labialis Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Novartis Herpes Labialis Treatment Products Offered
      • 11.8.5 Novartis Recent Development

    12 Future Forecast

    • 12.1 Herpes Labialis Treatment Market Forecast by Regions
      • 12.1.1 Global Herpes Labialis Treatment Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Herpes Labialis Treatment Revenue Forecast by Regions 2019-2025
    • 12.2 Herpes Labialis Treatment Market Forecast by Product
      • 12.2.1 Global Herpes Labialis Treatment Sales Forecast by Product 2019-2025
      • 12.2.2 Global Herpes Labialis Treatment Revenue Forecast by Product 2019-2025
    • 12.3 Herpes Labialis Treatment Market Forecast by End User
    • 12.4 North America Herpes Labialis Treatment Forecast
    • 12.5 Europe Herpes Labialis Treatment Forecast
    • 12.6 Asia Pacific Herpes Labialis Treatment Forecast
    • 12.7 Central & South America Herpes Labialis Treatment Forecast
    • 12.8 Middle East and Africa Herpes Labialis Treatment Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Herpes Labialis Treatment Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Herpes labialis, also known as cold sores, is a type of infection by the herpes simplex virus that affects primarily the lip. Symptoms typically include a burning pain followed by small blisters or sores. The first attack may also be accompanied by fever, sore throat, and enlarged lymph nodes. The rash usually heals within 10 days, but the virus remains dormant in the facial nerve. The virus may periodically reactivate to create another outbreak of sores in the mouth or lip.
      With over 35% value share, North America stood the top market for herpes labialis treatment in 2017. This region is expected to continue its dominance through the forecast period, followed by Western Europe, which recorded over 20% share of the total market value in 2017.
      The global Herpes Labialis Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Herpes Labialis Treatment market based on company, product type, end user and key regions.

      This report studies the global market size of Herpes Labialis Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Herpes Labialis Treatment in these regions.
      This research report categorizes the global Herpes Labialis Treatment market by top players/brands, region, type and end user. This report also studies the global Herpes Labialis Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Teva
      Abbott
      Sun
      Mylan
      Pfizer
      GlaxoSmithKline
      Dr. Reddy's
      Novartis

      Market size by Product
      Acyclovir
      Valacyclovir
      Famciclovir
      Penciclovir
      Docosanol
      Market size by End User
      Topical
      Oral

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Herpes Labialis Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Herpes Labialis Treatment market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Herpes Labialis Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Herpes Labialis Treatment submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Herpes Labialis Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Herpes Labialis Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now